Sensus Healthcare (SRTS) Stock Forecast, Price Target & Predictions
SRTS Stock Forecast
Sensus Healthcare stock forecast is as follows: an average price target of $10.00 (represents a 45.56% upside from SRTS’s last price of $6.87) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
SRTS Price Target
The average price target for Sensus Healthcare (SRTS) is $10.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $10.00 to $10.00. This represents a potential 45.56% upside from SRTS's last price of $6.87.
SRTS Analyst Ratings
According to 3 Wall Street analysts, Sensus Healthcare's rating consensus is 'Buy'. The analyst rating breakdown for SRTS stock is 0 'Strong Buy' (0.00%), 3 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Sensus Healthcare Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 13, 2024 | Raghuram Selvaraju | H.C. Wainwright | $10.00 | $5.56 | 79.86% | 45.56% |
| May 06, 2022 | H.C. Wainwright | $16.00 | $7.71 | 107.52% | 132.90% |
The latest Sensus Healthcare stock forecast, released on May 13, 2024 by Raghuram Selvaraju from H.C. Wainwright, set a price target of $10.00, which represents a 79.86% increase from the stock price at the time of the forecast ($5.56), and a 45.56% increase from SRTS last price ($6.87).
Sensus Healthcare Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $10.00 |
| Last Closing Price | $6.87 | $6.87 | $6.87 |
| Upside/Downside | -100.00% | -100.00% | 45.56% |
In the current month, the average price target of Sensus Healthcare stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Sensus Healthcare's last price of $6.87. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 13, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| May 04, 2023 | Needham | Buy | Buy | Hold |
| Nov 04, 2022 | Alliance Global Partners | Buy | Buy | Hold |
Sensus Healthcare's last stock rating was published by H.C. Wainwright on May 13, 2024. The company gave SRTS a "Buy" rating, the same as its previous rate.
Sensus Healthcare Financial Forecast
Sensus Healthcare Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $12.57M | $3.90M | $4.53M | $3.41M | $13.11M | $9.01M | $12.08M | $10.34M | $13.03M | $5.53M | $5.42M | $3.07M | $5.09M | $1.62M | $1.18M | $1.68M | $8.51M | $5.84M |
| Avg Forecast | $11.40M | $8.80M | $9.70M | $9.00M | $15.27M | $11.23M | $11.17M | $10.61M | $10.77M | $5.90M | $7.00M | $4.68M | $12.06M | $5.90M | $4.55M | $10.07M | $12.97M | $9.54M | $9.56M | $6.73M | $11.08M | $5.40M | $4.28M | $3.69M | $2.53M | $2.04M | $1.44M | $5.19M | $8.59M | $7.44M |
| High Forecast | $12.12M | $9.36M | $10.31M | $9.57M | $16.24M | $11.94M | $11.87M | $10.75M | $10.97M | $5.90M | $7.00M | $4.78M | $12.82M | $6.92M | $4.84M | $10.70M | $13.79M | $9.54M | $9.56M | $6.73M | $11.08M | $5.40M | $4.28M | $3.69M | $2.53M | $2.04M | $1.44M | $5.19M | $8.59M | $7.44M |
| Low Forecast | $10.54M | $8.14M | $8.97M | $8.32M | $14.12M | $10.39M | $10.33M | $10.46M | $10.55M | $5.90M | $7.00M | $4.58M | $11.15M | $5.12M | $4.21M | $9.31M | $12.00M | $9.54M | $9.56M | $6.73M | $11.08M | $5.40M | $4.28M | $3.69M | $2.53M | $2.04M | $1.44M | $5.19M | $8.59M | $7.44M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 5 | 9 | 6 | 4 | 4 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.04% | 0.66% | 0.99% | 0.34% | 1.01% | 0.94% | 1.26% | 1.54% | 1.18% | 1.02% | 1.27% | 0.83% | 2.02% | 0.79% | 0.82% | 0.32% | 0.99% | 0.79% |
Sensus Healthcare's average Quarter revenue forecast for Mar 24 based on 1 analysts is $4.68M, with a low forecast of $4.58M, and a high forecast of $4.78M. SRTS's average Quarter revenue forecast represents a -62.76% decrease compared to the company's last Quarter revenue of $12.57M (Dec 23).
Sensus Healthcare EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 5 | 9 | 6 | 4 | 4 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $5.64M | $-1.62M | $-1.13M | $-2.94M | $4.41M | $2.28M | $4.59M | $-8.85M | $5.32M | $322.00K | $-142.00K | $-907.00K | $1.25M | $-1.51M | $-2.41M | $-3.43M | $1.17M | $-596.43K |
| Avg Forecast | $-382.78K | $-295.48K | $-325.70K | $-302.20K | $-512.76K | $-377.15K | $-374.98K | $-356.10K | $-361.52K | $-198.25K | $-235.12K | $-2.39M | $-404.88K | $-198.12K | $-152.79K | $-1.89M | $2.91M | $-1.08M | $-1.08M | $-1.49M | $-1.26M | $-612.88K | $-485.54K | $-1.18M | $-286.66K | $-231.32K | $-162.81K | $-3.92M | $-973.80K | $-843.41K |
| High Forecast | $-354.02K | $-273.28K | $-301.23K | $-279.49K | $-474.23K | $-348.81K | $-346.81K | $-351.13K | $-354.19K | $-198.25K | $-235.11K | $-1.91M | $-374.45K | $-171.84K | $-141.31K | $-1.51M | $3.50M | $-1.08M | $-1.08M | $-1.19M | $-1.26M | $-612.88K | $-485.54K | $-943.28K | $-286.66K | $-231.32K | $-162.81K | $-3.14M | $-973.80K | $-843.41K |
| Low Forecast | $-406.95K | $-314.14K | $-346.27K | $-321.28K | $-545.14K | $-400.96K | $-398.66K | $-361.08K | $-368.49K | $-198.26K | $-235.13K | $-2.86M | $-430.44K | $-232.49K | $-162.44K | $-2.26M | $2.33M | $-1.08M | $-1.08M | $-1.79M | $-1.26M | $-612.88K | $-485.54K | $-1.41M | $-286.66K | $-231.32K | $-162.81K | $-4.71M | $-973.80K | $-843.41K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -13.92% | 8.17% | 7.38% | 1.56% | 1.51% | -2.11% | -4.24% | 5.93% | -4.23% | -0.53% | 0.29% | 0.77% | -4.37% | 6.51% | 14.82% | 0.88% | -1.20% | 0.71% |
1 analysts predict SRTS's average Quarter EBITDA for Mar 24 to be $-2.39M, with a high of $-1.91M and a low of $-2.86M. This is -142.34% lower than Sensus Healthcare's previous annual EBITDA (Dec 23) of $5.64M.
Sensus Healthcare Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 5 | 9 | 6 | 4 | 4 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $4.21M | $-1.45M | $-380.00K | $-1.89M | $2.83M | $1.83M | $3.52M | $16.06M | $5.32M | $195.00K | $-279.00K | $-1.11M | $1.02M | $-1.69M | $-2.57M | $-3.59M | $1.04M | $-730.39K |
| Avg Forecast | $2.29M | $980.75K | $1.63M | $980.75K | $4.20M | $2.25M | $2.25M | $1.96M | $1.96M | $-163.46K | $381.39K | $-2.93M | $2.33M | $-294.22K | $-1.24M | $-2.32M | $2.91M | $2.06M | $2.16M | $-1.83M | $2.68M | $-272.23K | $-898.34K | $-1.45M | $-1.82M | $-2.21M | $-2.89M | $-4.10M | $462.78K | $-544.44K |
| High Forecast | $2.48M | $1.06M | $1.77M | $1.06M | $4.54M | $2.43M | $2.43M | $2.09M | $2.16M | $-147.49K | $384.12K | $-2.35M | $2.52M | $441.33K | $-1.12M | $-1.86M | $3.50M | $2.06M | $2.16M | $-1.47M | $2.68M | $-272.23K | $-898.34K | $-1.16M | $-1.82M | $-2.21M | $-2.89M | $-3.28M | $462.78K | $-544.44K |
| Low Forecast | $2.06M | $884.94K | $1.47M | $884.94K | $3.79M | $2.03M | $2.03M | $1.83M | $1.77M | $-176.88K | $378.67K | $-3.52M | $2.10M | $-735.56K | $-1.34M | $-2.78M | $2.33M | $2.06M | $2.16M | $-2.20M | $2.68M | $-272.23K | $-898.34K | $-1.74M | $-1.82M | $-2.21M | $-2.89M | $-4.92M | $462.78K | $-544.44K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.81% | 4.93% | 0.31% | 0.82% | 0.97% | 0.89% | 1.63% | -8.76% | 1.99% | -0.72% | 0.31% | 0.77% | -0.56% | 0.77% | 0.89% | 0.88% | 2.25% | 1.34% |
Sensus Healthcare's average Quarter net income forecast for Mar 24 is $-2.93M, with a range of $-3.52M to $-2.35M. SRTS's average Quarter net income forecast represents a -169.70% decrease compared to the company's last Quarter net income of $4.21M (Dec 23).
Sensus Healthcare SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 5 | 9 | 6 | 4 | 4 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $1.57M | $2.80M | $2.92M | $3.46M | $3.02M | $2.97M | $2.86M | $2.49M | $2.43M | $2.26M | $2.70M | $2.04M | $2.13M | $2.01M | $2.07M | $3.12M | $3.52M | $3.08M |
| Avg Forecast | $5.70M | $4.40M | $4.85M | $4.50M | $7.63M | $5.61M | $5.58M | $5.30M | $5.38M | $2.95M | $3.50M | $2.34M | $6.03M | $2.95M | $2.27M | $4.24M | $1.33M | $4.77M | $4.78M | $3.35M | $5.54M | $2.70M | $2.14M | $2.65M | $1.26M | $1.02M | $717.37K | $3.57M | $4.29M | $3.72M |
| High Forecast | $6.06M | $4.68M | $5.15M | $4.78M | $8.11M | $5.97M | $5.93M | $5.37M | $5.48M | $2.95M | $3.50M | $2.39M | $6.41M | $3.46M | $2.42M | $5.09M | $1.60M | $4.77M | $4.78M | $4.03M | $5.54M | $2.70M | $2.14M | $3.18M | $1.26M | $1.02M | $717.37K | $4.28M | $4.29M | $3.72M |
| Low Forecast | $5.27M | $4.07M | $4.48M | $4.16M | $7.06M | $5.19M | $5.16M | $5.23M | $5.27M | $2.95M | $3.50M | $2.29M | $5.57M | $2.56M | $2.10M | $3.40M | $1.07M | $4.77M | $4.78M | $2.68M | $5.54M | $2.70M | $2.14M | $2.12M | $1.26M | $1.02M | $717.37K | $2.85M | $4.29M | $3.72M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.26% | 0.95% | 1.29% | 0.82% | 2.27% | 0.62% | 0.60% | 0.74% | 0.44% | 0.84% | 1.26% | 0.77% | 1.69% | 1.97% | 2.88% | 0.88% | 0.82% | 0.83% |
Sensus Healthcare's average Quarter SG&A projection for Mar 24 is $2.34M, based on 1 Wall Street analysts, with a range of $2.29M to $2.39M. The forecast indicates a 48.60% rise compared to SRTS last annual SG&A of $1.57M (Dec 23).
Sensus Healthcare EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 5 | 9 | 6 | 4 | 4 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.26 | $-0.09 | $-0.02 | $-0.12 | $0.17 | $0.11 | $0.21 | $0.97 | $0.32 | $0.01 | $-0.02 | $-0.07 | $0.06 | $-0.10 | $-0.16 | $-0.22 | $0.06 | $-0.04 |
| Avg Forecast | $0.14 | $0.06 | $0.10 | $0.06 | $0.26 | $0.14 | $0.14 | $0.12 | $0.12 | $-0.01 | $0.02 | $-0.04 | $0.14 | $-0.02 | $-0.08 | $0.13 | $0.23 | $0.13 | $0.13 | $0.04 | $0.16 | $-0.02 | $-0.06 | $-0.10 | $-0.11 | $-0.14 | $-0.18 | $-0.09 | $0.03 | $-0.03 |
| High Forecast | $0.15 | $0.06 | $0.11 | $0.06 | $0.28 | $0.15 | $0.15 | $0.13 | $0.13 | $-0.01 | $0.02 | $-0.04 | $0.15 | $0.03 | $-0.07 | $0.14 | $0.25 | $0.13 | $0.13 | $0.04 | $0.16 | $-0.02 | $-0.06 | $-0.10 | $-0.11 | $-0.14 | $-0.18 | $-0.09 | $0.03 | $-0.03 |
| Low Forecast | $0.13 | $0.05 | $0.09 | $0.05 | $0.23 | $0.12 | $0.12 | $0.11 | $0.11 | $-0.01 | $0.02 | $-0.05 | $0.13 | $-0.04 | $-0.08 | $0.11 | $0.21 | $0.13 | $0.13 | $0.04 | $0.16 | $-0.02 | $-0.06 | $-0.10 | $-0.11 | $-0.14 | $-0.18 | $-0.09 | $0.03 | $-0.03 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.82% | 4.96% | 0.31% | -0.96% | 0.74% | 0.87% | 1.59% | 22.38% | 1.95% | -0.60% | 0.36% | 0.71% | -0.54% | 0.74% | 0.91% | 2.59% | 2.12% | 1.20% |
According to 1 Wall Street analysts, Sensus Healthcare's projected average Quarter EPS for Mar 24 is $-0.04, with a low estimate of $-0.05 and a high estimate of $-0.04. This represents a -116.67% decrease compared to SRTS previous annual EPS of $0.26 (Dec 23).
Sensus Healthcare Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| LUCD | Lucid Diagnostics | $0.81 | $2.50 | 208.64% | Buy |
| LUNG | Pulmonx | $6.13 | $13.00 | 112.07% | Buy |
| SGHT | Sight Sciences | $3.62 | $7.50 | 107.18% | Hold |
| RXST | RxSight | $38.04 | $70.14 | 84.38% | Buy |
| KIDS | OrthoPediatrics | $22.46 | $39.50 | 75.87% | Buy |
| OFIX | Orthofix Medical | $17.93 | $24.00 | 33.85% | |
| NPCE | NeuroPace | $11.52 | $15.00 | 30.21% | Buy |
| SRTS | Sensus Healthcare | $7.78 | $10.00 | 28.53% | Buy |
| CVRX | CVRx | $13.16 | $14.25 | 8.28% | Buy |
| SRDX | Surmodics | $39.96 | $39.50 | -1.15% | Buy |
| CLPT | ClearPoint Neuro | $16.34 | $15.00 | -8.20% | Buy |
| RCEL | AVITA Medical | $12.52 | $9.00 | -28.12% | Buy |